AIM IMMUNOTECH INC. Total Liabilities and Equity
AIM IMMUNOTECH INC. (AIM) had Total Liabilities and Equity of $12.73 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-07
- 2026-06-30: Liabilities and Equity $12.73M.
- 2026-03-31: Liabilities and Equity $8.59M.
- 2025-12-31: Liabilities and Equity $5.78M.
- 2025-09-30: Liabilities and Equity $5.49M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $12.73M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $8.59M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.78M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $5.49M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $4.13M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.25M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $8.61M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $13.59M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $15.71M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $16.19M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $19.38M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $27.86M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $33.62M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $37.46M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $40.49M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $46.28M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $50.88M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $54.16M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $57.70M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $63.08M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $66.72M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $74.09M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $64.58M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $64.16M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $50.12M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $42.41M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $20.75M 10-K · filed 2021-03-31 | $20.22M 10-K · filed 2020-03-30 |
| 2019-09-30 | $22.49M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $13.81M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $15.96M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $13.85M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $15.17M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $15.69M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $16.26M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $14.21M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $14.72M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $16.11M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $16.86M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $18.87M 10-K · filed 2018-03-30 | |
| 2016-09-30 | $21.58M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $21.92M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $21.50M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $22.80M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $26.50M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $29.87M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $30.79M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $29.44M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $30.64M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $33.55M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $35.01M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $31.87M 10-K · filed 2015-03-19 | |
| 2013-09-30 | $42.88M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $46.14M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $51.66M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $57.70M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $48.58M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $41.11M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $42.73M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $43.51M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $45.53M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $47.60M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $51.68M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |